AbbVie is a global, research-based biopharmaceutical company formed in 2013 following its spin-off from Abbott Laboratories. The company's business model is centered around discovering, developing, and delivering innovative medicines that address serious health issues. AbbVie's portfolio includes treatments for conditions such as immunology, oncology, virology, and neuroscience. The company leverages its scientific expertise, patient-centric approach, and strategic collaborations to drive growth and maintain a competitive edge.
Classification: Cash Cow Explanation: Humira has been a blockbuster drug for AbbVie, generating significant revenue over the years. Despite facing increasing competition from biosimilars, it still holds a dominant position in the market for autoimmune disease treatments. Its market share remains high, but growth has slowed due to competition and market saturation.
Classification: Star Explanation: Imbruvica is a key player in the oncology market, particularly for chronic lymphocytic leukemia (CLL). It has a ...
Our BCG tool allows you to fill out the matrix with your own products.
It's like ChatGPT but for your university course. Ask questions about your course material and get instant answers with citations.